Please login to the form below

Not currently logged in
Email:
Password:

Longitude Prize

This page shows the latest Longitude Prize news and features for those working in and with pharma, biotech and healthcare.

Longitude Prize awards grants for antibiotic test development

Longitude Prize awards grants for antibiotic test development

Daniel Berman, Longitude Prize lead at UK innovation foundation Nesta, said: “The groups receiving these grants are working across a range of technologies, from nanosensors to gene detectors to lasers, but ... Launched by David Cameron at the G8 Summit

Latest news

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Tackling antimicrobial resistance on multiple fronts Tackling antimicrobial resistance on multiple fronts

    Indeed, the innovations in the race to win the Longitude Prize, an £8m challenge prize to accelerate the development of a rapid, affordable point-of-care diagnostic test to reduce overuse ... The Longitude Prize. From a design perspective, we know that

  • The AMR threat The AMR threat

    Dame Sally has worked hard to raise awareness of the challenges involved in tackling antibiotic resistance, and she helped bring it to a world stage via the innovative Longitude Prize. ... Launched at the 2013 G8 meeting, the prize supports research into

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...